// App-Quantinova.ai

PB0466 : Physician practice behaviors surrounding dose-reduction of direct oral anticoagulants for the extended phase treatment of venous thromboembolism

Researchers

Presenter

  • S. Woller

Principal Investigators

  • R. Rosovsky

  • K. Sanfilippo

  • L. Baumann Kreuziger

  • M. Gaddh

  • E. Eyster

  • K. Martin

Medical Centers

  • Intermountain Medical Center, Intermountain Healthcare, MURRAY, Utah, United States

  • Intermountain Medical Center, Murray, United States

  • Massachusetts General Hospital, Boston, MA, United States

  • Washington University, St. Louis, Missouri, United States

  • Medical College of Wisconsin, Milwaukee, Wisconsin , United States

  • Mercer University School of Medicine, Macon, Georgia, United States

  • Penn State University School of Medicine, State College, Pennsylvania, United States

  • Northwestern Memorial Hospital, Chicago, Illinois, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved